{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:56:21Z","timestamp":1785786981559,"version":"3.56.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1097\/01.mlr.0000108746.69256.45","type":"journal-article","created":{"date-parts":[[2004,1,19]],"date-time":"2004-01-19T04:05:15Z","timestamp":1074485115000},"page":"164-175","source":"Crossref","is-referenced-by-count":88,"title":["Health-Related Quality of Life Among Patients With Breast Cancer Receiving Zoledronic Acid or Pamidronate Disodium for Metastatic Bone Lesions"],"prefix":"10.1097","volume":"42","author":[{"given":"Kevin P.","family":"Weinfurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana D.","family":"Castel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin W.","family":"Timbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alastair","family":"Glendenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J Clin Oncol"},{"key":"R2-10-20210211","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1097\/00005650-200206001-00007","article-title":"Individual differences in quality-of-life treatment response","volume":"40","author":"Donaldson","year":"2002","journal-title":"Med Care"},{"key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/JCO.2000.18.4.743","article-title":"Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life","volume":"18","author":"Bower","year":"2000","journal-title":"J Clin Oncol"},{"key":"R4-10-20210211","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0895-4356(92)90096-6","article-title":"Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer","volume":"45","author":"Ganz","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R6-10-20210211","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s001980050178","article-title":"A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture","volume":"9","author":"Hall","year":"1999","journal-title":"Osteoporos Int"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0885-3924(98)00069-4","article-title":"Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases","volume":"16","author":"Janjan","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group","volume":"334","author":"Berenson","year":"1996","journal-title":"N Engl J Med"},{"key":"R9-10-20210211","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group","volume":"16","author":"Berenson","year":"1998","journal-title":"J Clin Oncol"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"N Engl J Med"},{"key":"R11-10-20210211","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.1998.16.6.2038","article-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group","volume":"16","author":"Hortobagyi","year":"1998","journal-title":"J Clin Oncol"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z","article-title":"Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials","volume":"88","author":"Lipton","year":"2000","journal-title":"Cancer"},{"key":"R13-10-20210211","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group","volume":"17","author":"Theriault","year":"1999","journal-title":"J Clin Oncol"},{"key":"R14-10-20210211","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650090521","article-title":"Preclinical pharmacology of CGP 42\u2032446, a new, potent, heterocyclic bisphosphonate compound","volume":"9","author":"Green","year":"1994","journal-title":"J Bone Miner Res"},{"key":"R15-10-20210211","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J"},{"key":"R17-10-20210211","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"R19-10-20210211","first-page":"69","article-title":"Clinically available evaluation of bone disease in breast cancer\u2014validity and cost effectiveness","volume":"5","author":"Coleman","year":"1995","journal-title":"Can J Oncol"},{"key":"R21-10-20210211","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2307\/2533455","article-title":"Variance components testing in the longitudinal mixed effects model","volume":"50","author":"Stram","year":"1994","journal-title":"Biometrics"},{"key":"R23-10-20210211","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R25-10-20210211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00019053-199915020-00003","article-title":"Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II","volume":"15","author":"Samsa","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"R26-10-20210211","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.1998.16.4.1588","article-title":"Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine","volume":"16","author":"Payne","year":"1998","journal-title":"J Clin Oncol"},{"key":"R27-10-20210211","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/1097-0142(19920401)69:7<1729::AID-CNCR2820690714>3.0.CO;2-D","article-title":"Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery?","volume":"69","author":"Ganz","year":"1992","journal-title":"Cancer"},{"key":"R28-10-20210211","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"key":"R29-10-20210211","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00540023","article-title":"An exploratory study of frequent pain measurement in a cancer clinical trial","volume":"5","author":"Ingham","year":"1996","journal-title":"Qual Life Res"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mlr.0000108746.69256.45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:02:57Z","timestamp":1785783777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005650-200402000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mlr.0000108746.69256.45","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}